We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+3.86%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
-$511K
Cap. Flow
-$4.31M
Cap. Flow %
-1.81%
Top 10 Hldgs %
56.07%
Holding
204
New
16
Increased
9
Reduced
10
Closed
19

Top Buys

Rank Stock Value
1
CDXS icon
Codexis
CDXS
+$1.79M
2
GSK icon
GSK
GSK
+$1.52M
3
FIP icon
FTAI Infrastructure
FIP
+$1.21M
4
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
+$1.01M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$920K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.65M
2
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$3.07M
3
INCY icon
Incyte
INCY
+$2.04M
4
INVA icon
Innoviva
INVA
+$1.7M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.48M

Sector Composition

Rank Sector Weight
1 Healthcare 32.49%
2 Materials 25.45%
3 Financials 10.86%
4 Real Estate 6.17%
5 Communication Services 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COP icon
151
ConocoPhillips
COP
$141B
$12K 0.01%
113
– –
GNRC icon
152
Generac Holdings
GNRC
$11.6B
$12K 0.01%
69
– –
TSLA icon
153
Tesla
TSLA
$1.22T
$12K 0.01%
45
– –
CRM icon
154
Salesforce
CRM
$142B
$11K ﹤0.01%
77
– –
DIS icon
155
Walt Disney
DIS
$168B
$11K ﹤0.01%
116
– –
ISRG icon
156
Intuitive Surgical
ISRG
$128B
$11K ﹤0.01%
61
– –
IWN icon
157
iShares Russell 2000 Value ETF
IWN
$14.4B
$11K ﹤0.01%
86
– –
LULU icon
158
lululemon athletica
LULU
$13.4B
$11K ﹤0.01%
39
– –
ARCH
159
DELISTED
Arch Resources, Inc.
ARCH
$11K ﹤0.01%
1,229
– –
ADBE icon
160
Adobe
ADBE
$94.5B
$10K ﹤0.01%
35
– –
RMR icon
161
The RMR Group
RMR
$348M
$10K ﹤0.01%
414
– –
SLB icon
162
SLB Ltd
SLB
$76.5B
$10K ﹤0.01%
292
– –
VZ icon
163
Verizon
VZ
$198B
$10K ﹤0.01%
263
-16,728
-98% -$745K
AGAC
164
DELISTED
African Gold Acquisition Corp
AGAC
$10K ﹤0.01%
1,000
– –
SDIG
165
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
$9K ﹤0.01%
909
-19,023
-95% -$370K
NKE icon
166
Nike
NKE
$62.5B
$8K ﹤0.01%
91
– –
PCAR icon
167
PACCAR
PCAR
$70.2B
$8K ﹤0.01%
149
– –
STWD icon
168
Starwood Property Trust
STWD
$6.15B
$7K ﹤0.01%
400
– –
WDAY icon
169
Workday
WDAY
$36.4B
$7K ﹤0.01%
45
– –
EWUS icon
170
iShares MSCI United Kingdom Small-Cap ETF
EWUS
$41.4M
$6K ﹤0.01%
246
– –
ABT icon
171
Abbott
ABT
$182B
$5K ﹤0.01%
50
– –
DBRG icon
172
DigitalBridge
DBRG
$2.93B
$5K ﹤0.01%
366
-1
-0.3% -$19
AMLP icon
173
Alerian MLP ETF
AMLP
$12.7B
$4K ﹤0.01%
120
– –
PG icon
174
Procter & Gamble
PG
$346B
$4K ﹤0.01%
35
– –
EWG icon
175
iShares MSCI Germany ETF
EWG
$1.55B
$3K ﹤0.01%
150
– –
4 5 6
7
8

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return
IWA
Integrity Wealth Advisors Ventura, California $168M AUM 18.33% 1-Year Est. Return

David M. Knott Jr's Q3 2022 Portfolio in Review

As of Q3 2022, David M. Knott Jr held 204 positions worth $238M, down 0.21% from $238M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

David M. Knott Jr's Q3 2022 filing shows 16 new, 9 increased, 10 reduced and 19 closed positions. Its largest new stake was Codexis: 222,107 shares worth $1.35M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $3.65M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Materials and Financials.

  • David M. Knott Jr's largest Q3 2022 buy was Codexis: 222,107 shares worth $1.35M.
  • David M. Knott Jr added most to F-star Therapeutics, Inc. Common Stock in Q3 2022, an estimated $1.01M increase.
  • David M. Knott Jr's biggest Q3 2022 reduction was Incyte, cutting an estimated $2.04M.
  • David M. Knott Jr fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $3.65M.
  • David M. Knott Jr's ten largest holdings make up 56% of its $238M portfolio in Q3 2022.
  • David M. Knott Jr opened 16 new positions and closed 19 in Q3 2022.
  • David M. Knott Jr's portfolio value fell 0.21% quarter-over-quarter to $238M.

Based on David M. Knott Jr's 13F filing for Q3 2022, filed 10 Nov 2022.